0001161697-22-000319.txt : 20220623
0001161697-22-000319.hdr.sgml : 20220623
20220623170237
ACCESSION NUMBER: 0001161697-22-000319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220621
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGENITO GARY
CENTRAL INDEX KEY: 0001279473
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221036193
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1500
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 06-21-2022
X0306
4
2022-06-21
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001279473
INGENITO GARY
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Medical & Reg. Officer
Common stock, par value $0.001 per share
2022-06-21
4
M
0
143848
4.13
A
165901
D
Common stock, par value $0.001 per share
2022-06-21
4
S
0
143848
6.595
D
22053
D
Common stock, par value $0.001 per share
2022-06-22
4
M
0
6152
4.13
A
28205
D
Common stock, par value $0.001 per share
2022-06-22
4
S
0
6152
6.607
D
22053
D
Options to purchase common stock
4.13
2022-06-21
4
M
0
143848
0
D
2022-06-30
Common Stock
143848
1077819
D
Options to purchase common stock
4.13
2022-06-22
4
M
0
6152
0
D
2022-06-30
Common Stock
6152
1071667
D
Dr. Ingenito sold the shares on the open market for personal reasons and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
Shares were sold in various lots from $6.55 to $6.68 per share. The listed sale price represents a weighted average price for the shares sold.
Shares were sold in various lots from $6.55 to $6.71 per share. The listed sale price represents a weighted average price for the shares sold.
Options vested in three annual tranches beginning on June 30, 2016.
/s/ Gary Ingenito
2022-06-23